Department of Epidemiology, School of Public Health, Brown University, Providence, RI.
Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI.
J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):151-156. doi: 10.1097/QAI.0000000000003042.
The coronavirus disease 2019 (COVID-19) pandemic continues to put strain on health systems in the United States, leading to significant shifts in the delivery of routine clinical services, including those offering HIV pre-exposure prophylaxis (PrEP). We aimed to assess whether individuals discontinued PrEP use at higher rates during the COVID-19 pandemic and the extent to which disruptions to usual clinical care were mitigated through telehealth.
Using data from an ongoing prospective cohort of men who have sex with men (MSM) newly initiating PrEP in 3 mid-sized cities (n = 195), we calculated the rate of first-time discontinuation of PrEP use in the period before the COVID-19 pandemic and during the COVID-19 pandemic and compared these rates using incidence rate ratios (IRRs). Furthermore, we compared the characteristics of patients who discontinued PrEP use during these periods with those who continued to use PrEP during both periods.
Rates of PrEP discontinuation before the COVID pandemic and during the COVID-19 pandemic were comparable [4.29 vs. 5.20 discontinuations per 100 person-months; IRR: 1.95; 95% confidence interval (CI): 0.83 to 1.77]. Although no significant differences in the PrEP discontinuation rate were observed in the overall population, the rate of PrEP discontinuation increased by almost 3-fold among participants aged 18-24 year old (IRR: 2.78; 95% CI: 1.48 to 5.23) and by 29% among participants covered by public insurance plans at enrollment (IRR: 1.29; 95% CI: 1.03 to 5.09). Those who continued to use PrEP were more likely to have had a follow-up clinical visit by telehealth in the early months of the pandemic (45% vs. 17%).
In this study, rates of PrEP discontinuation were largely unchanged with the onset of the COVID-19 pandemic. The use of telehealth likely helped retain patients in PrEP care and should continue to be offered in the future.
2019 年冠状病毒病(COVID-19)大流行继续给美国的卫生系统带来压力,导致常规临床服务的提供发生重大转变,包括提供艾滋病毒暴露前预防(PrEP)。我们旨在评估 COVID-19 大流行期间是否有更多人停止使用 PrEP,以及通过远程医疗在多大程度上减轻了常规临床护理的中断。
利用正在进行的前瞻性队列中在 3 个中等城市首次开始接受 PrEP 的男男性行为者(MSM)的数据(n=195),我们计算了 COVID-19 大流行前和大流行期间首次停止使用 PrEP 的发生率,并使用发病率比值(IRR)比较了这些发生率。此外,我们比较了在这些时期停止使用 PrEP 的患者与在两个时期都继续使用 PrEP 的患者的特征。
在 COVID 大流行之前和 COVID-19 大流行期间,PrEP 停药率相当[4.29 与 5.20 例/100人月;IRR:1.95;95%置信区间(CI):0.83 至 1.77]。尽管在总体人群中未观察到 PrEP 停药率的显著差异,但在 18-24 岁的参与者中,PrEP 停药率增加了近 3 倍(IRR:2.78;95%CI:1.48 至 5.23),而在入组时通过公共保险计划覆盖的参与者中,PrEP 停药率增加了 29%(IRR:1.29;95%CI:1.03 至 5.09)。那些继续使用 PrEP 的人更有可能在大流行早期通过远程医疗进行随访(45%比 17%)。
在这项研究中,随着 COVID-19 大流行的开始,PrEP 停药率基本保持不变。远程医疗的使用可能有助于保留 PrEP 护理患者,未来应继续提供。